This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

NCT02772601 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Caffeine
DRUG: Warfarin
DRUG: Omeprazole
DRUG: Metoprolol
DRUG: Midazolam
DRUG: Risankizumab

Sponsor

AbbVie

Collaborators

[object Object]